| The Optimal Management for Cervical Carotid Stenosis: Feasibility of Carotid Artery Stenting |
|
Eui-Gyu Sin1 , Cheol-Young Lee1,2 , Hyun-Woo Kim1 , Ho-Gyun Ha1 , Chul-Ku Jung1 |
|
1Department of Neurosurgery, Konyang University College of Medicine, Daejon, Korea
2Graduate School of Medicine, Kyung-Hee University College of Medicine, Seoul, Korea |
|
|
| Abstract |
Objective
In the past, carotid artery stenting (CAS) has been regarded as an alternative method to carotid endarterectomy (CEA). But currently, it is widely used as a first line treatment for cervical carotid stenosis. In this study, we analyzed clinical outcomes of 31 patients with cervical carotid stenosis and invested the effectiveness of CAS as a primary treatment.
Methods
From June 2011 to April 2013, 31 patients who performed CAS for cervical carotid stenosis were included. Clinical data, angiographic findings and procedure related complications were analyzed retrospectively.
Results
26 patients (84%) already had medical problems such as coronary heart disease, hypertension, diabetic, previous infarction or hyperlipidemia. The mean stenosis rate was 80% (from 65% to 91%). After treatment, average of residual stenosis rate was 21%. The procedures were technically successful in all cases. The number of patients with improved or unchanged symptoms compared with pre-treatment state was 29 (94%). During 30-day periods, there was no major stroke or restenosis. Procedure related morbidity was 3%. 1 patients experienced new minor infarction. Restenosis was noted in 1 patient at 5 month later.
Conclusion
Our clinical results of CAS were not inferior to other methods in the previously published. This study carefully suggests that CAS can be safe and useful first line treatment for cervical carotid artery stenosis. |
| Key Words:
Carotid artery stentingㆍCervical carotid StenosisㆍEndovascular stentingㆍStent insertionㆍEndarterectomy |
|
PDF Links
Download Citation
